Analyst Ratings February 4, 2026

Mizuho Lowers Cabot Rating to Neutral, Cuts Price Target to $75 Citing Weak Carbon Black Demand

Analyst trims EPS forecasts after subdued guidance from Cabot’s December quarter and flags lack of recovery in tire and rubber demand

By Avery Klein CBT
Mizuho Lowers Cabot Rating to Neutral, Cuts Price Target to $75 Citing Weak Carbon Black Demand
CBT

Mizuho downgraded Cabot Corporation (NYSE: CBT) from Outperform to Neutral and reduced its 12-month price target to $75 from $80. The research firm cited continued weakness in carbon black demand from tire and rubber products and trimmed its fiscal 2026 and 2027 EPS estimates. The move follows Cabot’s December quarter 2025 report, which included guidance for the remaining nine months of fiscal 2026 that came in below Mizuho’s prior outlook.

Key Points

  • Mizuho downgraded Cabot from Outperform to Neutral and lowered the price target to $75 from $80, citing weak demand for carbon black in tire and rubber products.
  • Mizuho reduced fiscal 2026 EPS to $6.30 from $6.65 and fiscal 2027 EPS to $6.95 from $7.60, both below Bloomberg consensus.
  • Cabot reported Q1 EPS of $1.53, beating expectations; Jefferies raised its price target to $85 and the company completed the acquisition of Mexico Carbon Manufacturing S.A. de C.V.

Overview

Mizuho has lowered its rating on Cabot Corporation (NYSE: CBT) from Outperform to Neutral and reduced its price target to $75 from $80. The specialty chemicals producer is quoted at $78.73 and carries a price-to-earnings ratio of 13.29, according to InvestingPro data.

Reasoning behind the downgrade

The research house pointed to a persistently weak demand environment for carbon black in tire and rubber products - a core segment of Cabot’s business - and concluded that there is no recovery visible in the near term. As part of its reassessment, Mizuho trimmed its earnings per share forecasts to reflect the softer demand outlook. Fiscal 2026 EPS was lowered to $6.30 from $6.65, and fiscal 2027 EPS was reduced to $6.95 from $7.60. Both of these projections sit beneath the current Bloomberg consensus estimates of $6.46 for 2026 and $7.15 for 2027.

Recent company results and guidance

The downgrade follows Cabot’s December quarter 2025 results. Those results included updated earnings guidance covering the remaining nine months of fiscal year 2026 that was approximately 8% below Mizuho’s prior estimate, prompting the analyst to rework both near-term forecasts and the stock rating.

Valuation framework

Mizuho’s revised $75 price target reflects an implied next-twelve-months price-to-earnings multiple near 10.5x. The firm notes that this multiple equates to roughly 0.67 times the S&P SMIDCap SpecialtyChem Index, versus a five-year median of about 0.59, indicating Mizuho’s view of relative valuation within the specialty chemicals peer group.

Market moves and performance

Mizuho also observed that Cabot shares have climbed roughly 36% from their November low. InvestingPro data cited in the research note shows an 18.78% year-to-date return for the stock, though the share price remains down 8.59% over the trailing 12 months.

Other recent developments at Cabot

Separately, Cabot reported first-quarter earnings per share of $1.53, beating consensus and Jefferies’ forecast by $0.20. After that report, Jefferies raised its price target on Cabot to $85 while keeping a Buy rating. The company also finalized the acquisition of Mexico Carbon Manufacturing S.A. de C.V., a deal completed after obtaining regulatory approvals that places the acquired operations near Cabot’s existing Altamira, Mexico facility and is intended to bolster the company’s global manufacturing footprint and operational flexibility in reinforcing carbon products.

Cabot announced proposed changes to its board, including the nomination of Thierry Vanlancker for election at the 2026 Annual Meeting, with a potential term extending to 2029. On the sustainability front, Cabot earned an A- rating for Water Security from CDP, an improvement from a B in 2024, while its Climate Change score remained at B. In addition, Jefferies previously raised a separate Cabot price target to $81 tied to a supply agreement with PowerCo for conductive carbons used in electric vehicle batteries in Europe.

What this means for investors

Mizuho’s downgrade and lower EPS outlook reflect the firm’s assessment that carbon black demand in key markets remains subdued and that near-term company guidance is weaker than previously modeled. The adjusted valuation multiple and downward estimate revisions signal a more cautious stance from the analyst amid these demand headwinds.


Summary

Mizuho cut Cabot to Neutral and trimmed its price target to $75 after the company’s December quarter guidance came in below prior expectations and the analyst concluded there is no sign of recovery in carbon black demand for tire and rubber products. The firm reduced fiscal 2026 and 2027 EPS estimates and set its valuation at roughly 10.5x next-twelve-months earnings, or about 0.67 times the S&P SMIDCap SpecialtyChem Index.

Risks

  • Sustained weakness in tire and rubber demand for carbon black, which could continue to pressure Cabot’s revenues and margins - impacting the specialty chemicals and automotive supply chain sectors.
  • Company guidance that is lower than analyst expectations, such as the December quarter 2025 outlook that was about 8% below Mizuho’s prior estimate, increasing forecast uncertainty for investors in specialty chemicals.
  • Relative valuation shifts within the S&P SMIDCap SpecialtyChem Index could alter investor perception of Cabot versus peers if market multiples move, affecting investment flows into the specialty chemicals sector.

More from Analyst Ratings

Stifel Lifts Civeo Price Target to $33, Citing Growth Across Australian and North American Operations Feb 4, 2026 Evercore Sees Cisco as Key Supplier for AI Infrastructure, Keeps Outperform Rating Feb 4, 2026 DA Davidson Raises Varonis Systems to Buy, Lifts Target to $30 as Analyst Views Turn More Positive Feb 4, 2026 Clear Street Sticks with Buy on Palvella Ahead of Phase 3 SELVA Readout Feb 4, 2026 Lineage Shares Jump After Barclays Sticks with Equalweight Rating Despite Data Center Deal Feb 4, 2026